Year: 2019

A “rheostat” for cancer signals

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

From left, Ryan Allen, PhD, MacRae Linton, MD, Kasey Vickers, PhD, Quanhu Sheng, PhD, and colleagues are working to create a new model of atherosclerosis development. (photo by Susan Urmy)

VUMC investigators receive Keck Foundation award for novel atherosclerosis research

A team of researchers has received a $1 million grant from the W.M. Keck Foundation to explore a novel model of atherosclerosis development.

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Churchwell named to Roundtable on Black Men and Black Women in Science, Engineering and Medicine

Andre Churchwell, MD, Chief Diversity Officer for Vanderbilt University Medical Center and senior associate dean for Diversity Affairs for Vanderbilt University School of Medicine, has been named to the Roundtable on Black Men and Black Women in Science, Engineering and Medicine.

New Physician Spotlight: Niels Johnsen

Niels Johnsen, MD, has joined the Vanderbilt University Medical Center Department of Urology after completing his residency at VUMC. He began seeing patients Aug. 1.

Cancer susceptibility genes

Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations.

1 26 27 28 29 30 74